SEARCH
Tynax ~ Patent Library

Patent for Sale:

FDA Approved Medical Device with Patented Lab Process    

A tampon like device collects menstrual fluids and analyses for various diseases: cervical endometrial cancers HPV, STDs, Hepatitis, TB/DNA, HPV, HIV/AIDS, Stem cells, Chlamydia, open ending lab test

Overview

A non-invasive medical device, patents cover all body cavities - vaginal, anus, ear, nose, mouth to test for many disease indications. Product is market ready.

HIGHLIGHTS:

Studies have been completed for the early detection of diseases. Sample product has been made and is available. Mold in first rate US FDA approved white room facility. Ready to make product rollout. All FDA approved materials for making the product device is provided by medically approved suppliers and is housed at the FDA approved injection molder in USA.

The device can provide multiple tests, with no needles. The tampon-like device kit can be provided by mobile clinics, and lead to mobile labs with the lab process. Labs are in place that can take the tampon-like device in its liquid based collection and be used in already protocols as well in place in the current labs. Collection can be in the privacy or the patients home and then sent to the lab, or taken back to a mobile clinic for collection on site. Samples are secure in approved preservative and/or fixative in an approved sterile vial (approved also for US postal mailings to the lab).

Patents cover other areas that can lead to home detection kits that provide immediate results.

This technology provides a better solution than a Pap smear, it eliminates the need for the physician to perform the smear test.

Monoclonal antibody tags can track indications and the device can also be used as a treatment device.

Medical Testing Market - The pap test market for cervical cancer, endometrial cancer, HPV, HIV aids testing, all testing for sexually transmitted diseases, DNA, TB. The technology can extend to males via the anus and mouth testing for diseases, and even to animals for genetic testing and other disease indications as well.

Newly issued patent of January 2012 providing new patent in South Africa (a hotbed of diseases) for device and its own lab process that could also be mobile. This patent has provided an avenue for PCT filings now being done in up to 144 countries.

OVERVIEW:

This device collects menstrual blood from patients for cytology and clinical analysis. It has U.S. FDA approval as a collection device. It is a painless, self-administered device, which supports tests with up to 98% accuracy rating for HIV/AIDS and for any other Sexually Transmitted Diseases (STDs) (SDIs) that can be detected with a blood assay. It can also replace the current scraping sample procedure used for PAP smear tests.

Successful treatment of many diseases, including HIV/AIDS, relies on early detection. Worldwide, very few women submit themselves to STDs/STIs tests, despite the fact that these infections increase the risk to women of contracting HIV/AIDS. 360 Million woman have an STD and many do not know it. This device provides women the opportunity to test themselves for many opportunistic diseases, thus dramatically expanding medical care coverage in the US as well as impoverished, remote or field environments.

This non-toxic, tampon-like device offers a non-invasive collection device that is:

- Used at a woman’s convenience in the privacy of her own home to test for a wide variety of diseases that can be detected through a blood assay, without requiring the use of needles.

- An aid encouraging women to have themselves tested more frequently for diseases such as cervical cancer, HPV, HIV/AIDS, Sexually Transmitted Diseases (STDs) and other opportunistic diseases as well as hepatitis, TB, malaria, thyroid and collagen disorders.

- An alternative to a doctor or lab visit for a Pap smear or blood draw, offering benefits and economies related to savings on clinical visits in both the developed and developing world.

- Empowering women by providing a home-sample collection device technology compatible with existing lab protocols.

- Valuable in widespread epidemiological studies to capture information on a variety of diseases, as one sample can be used for several tests.

- Ideal in developing countries where issues of access to medical care, complications from contaminated needles, and cultural taboos related to gynecological services compromise women’s health

Not since the introduction of the birth control pill has there been a women’s healthcare product that so powerfully affirms their rights to privacy and convenience for a non-invasive, painless and non-humiliating procedure. This home collection system will revolutionize preventative medicine capabilities for women worldwide by early detection.

MARKET:

There is a global market for this technology, it can be made available to any woman who has a menstrual cycle. In the USA the market size for cervical cancer testing alone is $6 Billion annually. Also cell collection can be made available on post menopausal women by providing a hormone tablet to produce "occult bleeding" for collection of blood. In addition, the product can also be used when not menstruating to collect cells with modification as per the patents as well. It can be used to show "metabolic clinical parameters" which has only be obtainable by a needle blood drawn prior.

Primary Application of the Technology

Laboratories
Clinics
Drug Companies
Medical Clinics
HMOs,
Insurance Companies,
Foundations like Gates,
Health Care Facilities,
Medicare
Medicade
Prison Testing Facilities
Military Facilities
College Campus Student Health Centers
Faith Based Organizations
Social Networking Sites
Planned Parenthood sites and the like

The Problem Solved by the Technology

The technology provides multiple tests from one collection of menstrual fluids and cells, no one else can do this without infringing on the device. It is a method that can collect with unlimited lab results at the source of area needed

How the Technology Solves the Problem

The device collects more living cells, more blood of interest, from the area of interest. The device is user friendly, the waive of the future is to mass screen with the best method for saving costs. Empowering woman to help themselves.

Competitive Advantage

Current Pap smear testing does not get enough cells of interest, it only tests for cervical cancer on one test, it has to be done by physician, it has to be repeated. This technology provides hundreds more living cells of interest, for a better reading, in a liquid based collection and can test for multiple diseases.

The patents extend to cover all body cavities, including the throat where HPV is causing throat cancers. The anus area where patents can develop other testing devices for anus tests, also the ear,mouth, and nose areas as well. The patented technology is non-invasive, time saving, and provides a sense of control to the patient. The patented technology costs less and provides more. This technology is very needed in the third world, where no needles are required.

The seller may consider selling these patents individually.

Additional Information

Some samples are available, the mold is part of the sale, it is ready in an FDA approved white room.

Product Availability: Working with the largest global lab in South Africa, the product is available in a small way through donations by a Foundation

Patent Summary

U.S. Patent Classes & Classifications Covered in this listing:

Class 600: Surgery

Subclass 575: Plural collection means (e.g., plural reservoirs or plural absorbent pads, etc.)
Subclass 582: Collection receptacle placed within body

Class 604: Surgery